Comment on "Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study" and a case report of glucagon-like peptide-1 receptor agonist-induced bullous pemphigoid

J Am Acad Dermatol. 2019 Jun;80(6):e189-e190. doi: 10.1016/j.jaad.2019.01.086. Epub 2019 Feb 7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Case-Control Studies
  • Dipeptidyl-Peptidase IV Inhibitors*
  • Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
  • Finland
  • Glucagon-Like Peptide-1 Receptor
  • Humans
  • Pemphigoid, Bullous*

Substances

  • Dipeptidyl-Peptidase IV Inhibitors
  • Glucagon-Like Peptide-1 Receptor
  • Dipeptidyl-Peptidases and Tripeptidyl-Peptidases